VIVS

+ Watchlist + Portfolio

VivoSim Labs, Inc.

Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.21
52-Week Range: $0.19 – $3.54
Market Cap: $3.26M
P/E (TTM): —
EPS (TTM): -4.47
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: —
PEG Ratio: —
Return on Equity: -343.10%
Return on Assets: -89.50%
Gross Margin: 0.00%
Operating Margin: -15327.78%
Profit Margin: 0.00%
Current Ratio: 1.70
Debt/Equity: —
Total Debt: $316.00K
Free Cash Flow: $-7.58M
Revenue Growth: -51.40%
Earnings Growth: —
Enterprise Value: $1.56M

VIVS Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Revenue	$370.00K	$109.00K	$144.00K	$131.00K
Cost of Revenue	—	$0.00	$5.00K	$0.00
Gross Profit	—	$109.00K	$139.00K	$131.00K
Research & Development	$8.88M	$5.50M	$5.03M	$4.19M
Selling, General & Admin	$9.09M	$9.64M	$7.69M	$7.41M
Operating Expenses	$18.10M	$15.20M	$12.76M	$11.62M
Operating Income	-$17.73M	-$15.09M	-$12.62M	-$11.49M
EBITDA	-$17.44M	-$14.39M	-$2.21M	-$13.61M
Pretax Income	-$17.26M	-$14.67M	-$2.49M	-$13.84M
Income Tax	$2.00K	$2.00K	$2.00K	$2.00K
Net Income	-$17.26M	-$14.67M	-$2.49M	-$13.84M
Diluted EPS	-23.76	-19.25	-1.70	-5.35
Diluted Shares	726085	762076	1.46M	2.59M

VIVS Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$15.30M	$2.90M	$11.31M	$5.02M
Receivables	$152.00K	$33.00K	$30.00K	$1.05M
Inventory	$0.00	$297.00K	$0.00	—
Current Assets	$17.05M	$3.94M	$12.13M	$6.63M
Total Assets	$20.31M	$6.35M	$14.65M	$7.39M
Current Liabilities	$3.67M	$1.86M	$3.74M	$2.79M
Total Debt	$1.80M	$1.39M	$942.00K	$447.00K
Total Liabilities	$4.98M	$2.75M	$4.16M	$8.48M
Retained Earnings	-$325.00M	-$339.67M	-$342.16M	-$356.00M
Shareholders' Equity	$15.33M	$3.60M	$10.49M	-$1.10M
Working Capital	$13.38M	$2.08M	$8.39M	$3.84M

VIVS Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	-$12.41M	-$14.65M	-$9.46M	-$10.83M
Capital Expenditure	-$396.00K	-$42.00K	-$13.00K	—
Free Cash Flow	-$12.80M	-$14.70M	-$9.47M	-$10.83M
Depreciation & Amortisation	$293.00K	$280.00K	$266.00K	$215.00K
Stock-Based Compensation	$2.38M	$1.51M	$532.00K	$303.00K
Investing Cash Flow	-$966.00K	$816.00K	$9.03M	$94.00K
Financing Cash Flow	$0.00	$1.44M	$8.85M	$4.45M
Net Change in Cash	-$13.37M	-$12.40M	$8.41M	-$6.29M

VIVS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$51.00K	$37.00K	$28.00K	$26.00K	$40.00K	$18.00K
Cost of Revenue	$0.00	$0.00	$0.00	$0.00	$0.00	—
Gross Profit	$51.00K	$37.00K	$28.00K	$26.00K	$40.00K	—
Research & Development	$859.00K	$1.00M	$923.00K	$1.14M	$1.13M	$1.13M
Selling, General & Admin	$2.34M	$1.95M	$1.74M	$1.63M	$2.10M	$1.64M
Operating Expenses	$3.21M	$2.95M	$2.66M	$2.78M	$3.23M	$2.78M
Operating Income	-$3.15M	-$2.92M	-$2.63M	-$2.75M	-$3.19M	-$2.76M
EBITDA	$6.92M	-$2.78M	-$2.48M	-$2.63M	-$5.72M	-$1.29M
Pretax Income	$6.85M	-$2.84M	-$2.54M	-$2.69M	-$5.76M	-$1.33M
Income Tax	$0.00	$0.00	$2.00K	$0.00	$0.00	$3.00K
Net Income	$6.85M	-$2.84M	-$2.54M	-$2.69M	-$5.76M	-$1.34M
Diluted EPS	—	-1.14	-0.98	-1.03	—	-0.25
Diluted Shares	—	2.49M	2.60M	2.61M	—	3.19M

VIVS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$11.31M	$9.05M	$6.68M	$4.29M	$5.02M	$1.67M
Receivables	$30.00K	$32.00K	$32.00K	$1.04M	$1.05M	$1.04M
Inventory	$0.00	—	—	—	—	—
Current Assets	$12.13M	$9.68M	$7.59M	$6.04M	$6.63M	$3.23M
Total Assets	$14.65M	$11.98M	$9.69M	$6.96M	$7.39M	$3.85M
Current Liabilities	$3.74M	$2.14M	$2.45M	$2.48M	$2.79M	$1.89M
Total Debt	$942.00K	$822.00K	$700.00K	$577.00K	$447.00K	$316.00K
Total Liabilities	$4.16M	$2.44M	$2.62M	$2.52M	$8.48M	$6.19M
Retained Earnings	-$342.16M	-$345.00M	-$347.55M	-$350.24M	-$356.00M	-$357.34M
Shareholders' Equity	$10.49M	$9.54M	$7.07M	$4.44M	-$1.10M	-$2.35M
Working Capital	$8.39M	$7.54M	$5.14M	$3.57M	$3.84M	$1.33M

VIVS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$2.04M	-$3.94M	-$2.38M	-$2.27M	-$2.24M	-$3.21M
Capital Expenditure	—	—	—	—	—	-$23.00K
Free Cash Flow	-$2.04M	-$3.94M	-$2.38M	-$2.27M	-$2.24M	-$3.24M
Depreciation & Amortisation	$61.00K	$61.00K	$59.00K	$52.00K	$43.00K	$40.00K
Stock-Based Compensation	$91.00K	$78.00K	$72.00K	$67.00K	$86.00K	$91.00K
Investing Cash Flow	$9.00M	$0.00	$0.00	$0.00	$94.00K	-$23.00K
Financing Cash Flow	$3.19M	$1.68M	$0.00	-$118.00K	$2.88M	-$118.00K
Net Change in Cash	$10.15M	-$2.26M	-$2.38M	-$2.39M	$736.00K	-$3.35M

Market Snapshot

About

VivoSim Labs, Inc. is a technology company focused on developing virtual SIM (eSIM) solutions and mobile connectivity platforms. The company provides software and services that enable seamless mobile network connectivity without physical SIM cards. VivoSim targets the growing market for IoT devices and international mobile connectivity.